Extensive evidence has revealed variations in the number of hormone-producing cells in the pituitary gland, which occur under physiological conditions such as gestation and lactancy. It has been proposed that new hormone-producing cells differentiate from stem cells. However, exactly how and when this takes place is not clear. In this work, we used immunoelectron microscopy to identify adult pituitary stem/progenitor cells (SC/P) localized in the marginal zone (MZ), and additionally, we detected GFRa2-, Sox2-, and Sox9-positive cells in the adenoparenchyma (AP) by fluorescence microscopy. Then, we evaluated fluctuations of SC/P mRNA and protein level markers in MZ and AP during gestation and lactancy. An upregulation in stemness markers was shown at term of gestation (AT) in MZ, whereas there were more progenitor cell markers in the middle of gestation and active lactancy. Concerning committed cell markers, we detected a rise in AP at beginning of lactancy (d1L). We performed a BrdU uptake analysis in MZ and AP cells. The highest level of BrdU uptake was observed in MZ AT cells, whereas in AP this was detected in d1L, followed by a decrease in both the MZ and AP. Finally, we detected double immunostaining for BrdU-GFRa2 in MZ AT cells and BrdU-Sox9 in the AP d1L cells. Taken together, we hypothesize that the expansion of the SC/P niche took place mainly in MZ from pituitary rats in AT and d1L. These results suggest that the SC niche actively participates in pituitary plasticity during these reproductive states, contributing to the origin of hormone cell populations.
gestation, and lactancy (22, 47) . This hormone output must be fine-tuned and adapt swiftly to changing needs, thereby requiring dynamic and accurate functional and quantitative remodeling of the hormonal cells (36, 45) . It has been described that the generation of new endocrine cells occurs in different ways, including the mitosis of already differentiated cells (10, 37) , transdifferentiation between distinct cell phenotypes (40, 50) , and differentiation of stem/progenitor cells (8) . All three processes combine their effects in dynamic cell adaptations, but a single mechanism may predominate depending on the particular physiological situation. The plasticity of the pituitary gland is in fact one of the most important features that allows the existence of stem cells (SC) to be postulated in this adult endocrine tissue (39) .
The development of the pituitary gland begins with a structure called Rathke's pouch, which invaginates from the oral ectoderm and grows out around the remaining lumen-denominated cleft. Embryonic progenitor cells appear to reside in the marginal zone (MZ) around the cleft. Indeed, cells in this zone markedly proliferate and ostensibly migrate to the emergent PD, where they develop further into different hormonal cell lineages (27) . During postnatal life, multilayered and heterogeneous MZ cells, referred to as the niche for putative pituitary SC, are able to retain some features of their embryonic nature (49) .
The SC have been reported in different adult organs on the basis of their capacity to proliferate and carry out self-renewal, a differentiation potential, and the ability to regenerate tissue after cell loss and are able to express key marker genes (32, 35, 41) , with the principal ones being the transcription factors Oct-4 and Sox2, which are involved in the maintenance of pluripotency in the genome of SC (48, 55) . The Sox9 progenitor marker, a member of the SoxE subfamily, is important in embryonic and postnatal development (9) and participates in differentiation programs by activation of tissue-specific genes (26) . In the pituitary gland, it has been postulated that the transcription factor Prop1 might play a role as a trigger in the terminal differentiation process of progenitor cells, leading to the development of endocrine cells (53, 54) . Prop1 positively regulates the expression of the pituitary-specific transcription factor Pit-1, with this factor being critical for normal thyrotroph, somatotroph, and lactotroph development. Furthermore, Prop1 and Pit-1 have been associated with the maturation of committed cell lineages (28, 44) .
Several nonendocrine cells have been described as being SC and proposed to maintain pituitary homeostasis by the generation of new endocrine cells. Nevertheless, the identity and functional position of adult pituitary SC and their role in the pituitary plasticity described in physiological conditions are not well understood. Numerous studies have been able to demonstrate that these nonendocrine cells in the adult pituitary gland express stemness markers; for example, a side population that efficiently excludes the Hoechst 33342 vital dye has been shown to generate sphere-forming cells (8) . Also, pituitary colony-forming cells that display a notable clonal potential have been isolated (30) . However, the only common marker studied for these cells was Sca1, and to date its position in the pituitary is not well established. The presence of Sox2ϩ and Sox9ϩ cells in the MZ and clusters scattering in the adenoparenchyma (AP) have allowed these transcription factors to be proposed as markers of pituitary SC/progenitors (SC/P) or transit-amplifying cells (15, 58) . In addition, a niche of putative SC/P in the pituitary expresses the Glial cell line-derived neurotropic factor receptor-␣2 (GFRa2), with this specific marker proposed for pituitary SC being localized in MZ cells (19) and recently detected in scarce AP cells (18) .
Extensive evidence has revealed significant changes in the number of different PD cell populations in certain defined physiological conditions to meet the endocrine demands of the organism (3), with an increased mitotic activity of lactotrophs being reported during the reproductive cycle and lactancy (2, 38) . However, exactly how and when this takes place is not clear. It has been proposed that during plastic adaptations and basic cell turnover, new hormone-producing cells differentiate from nonendocrine cells, which represent SC (36) . Therefore, gestation and lactancy represent an adequate physiological model to test cell differentiation of potential SC. In an attempt to elucidate this mechanism, we identified the SC/P in the pituitary gland by fluorescence and electron microscopy and evaluated the possible changes in SC/P-associated markers expressed in the MZ and the adenoparenchyma during gestation and lactancy. Furthermore, the specific contribution of these cells in the maintenance of pituitary homeostasis in response to physiological hormonal requirements was also analyzed.
MATERIALS AND METHODS
Animals and experimental design. Virgin female Wistar rats aged 10 -12 wk were examined by vaginal smear cytology and assigned to the estrous or diestrous II phases. Only rats that completed the estrous phases over two cycles were included in this study. Rats were mated with proven fertile males and then divided in the following groups: group A [gestation (G)], i.e., copula (COP), rats in the estrous phase that had sperm in their vaginal smear at 5 days of gestation after copula (d5G), at 15 days after copula (d15G), and at term of gestation (AT); and group B [lactancy (L)], i.e., pregnant rats that were transferred to individual cages until the day of parturition. At birth, the number of litters was adjusted to eight pups, and then the mothers were euthanized at the beginning of lactancy (d1L or early lactancy) or after 4 days of lactancy (d4L or active lactancy).
All rats were bred and housed at the Animal Research Facility of the INICSA-CONICET-School of Medicine, National University of Córdoba, under controlled temperature (21 Ϯ 3°C) and lighting conditions (14:10-h light-dark cycle), having free access to commercial rodent food and tap water. Animals were kept in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (1996) , and the experiments were approved by the Institutional Animal Care Committee of School of Medicine, National University of Córdoba.
Characterization of cells in the MZ by high-resolution light microscopy, transmission electron microscopy, and ultrastructural immunocytochemistry. MZ cells were studied in three hemipituitaries from each experimental group after being fixed by immersion in 4% (vol/vol) glutaraldehyde and 4% (wt/vol) formaldehyde in 0.1 M cacodylate buffer, treated with 1% osmium tetroxide (Sigma, St. Louis, MO), dehydrated, and embedded in Araldite (Electron Microscopy, Hatfield, PA). For high-resolution light microscopy analysis, semithin (200 m) sections were stained with blue toluidine, and MZ cells were observed. The MZ cell ultrastructures were analyzed in thin sections (60 m), stained with uranyl acetate/lead citrate, and examined in a Zeiss-Leo 906-E electron microscope.
For ultrastructural immunocytochemistry (UICC), the animals of each group were euthanized by decapitation, and pituitary glands were removed and cut into two small pieces in coronal orientation. Then, these glands were fixed for 4 h in 4% (wt/vol) formaldehyde with 0.75% (vol/vol) glutaraldehyde in 0.1 M cacodylate buffer. The fixed tissues were dehydrated by a series of increasing concentrations of ethanol and immersed in LR White (Electron Microscopy) before being embedded in gelatin capsules to avoid contact of the resin with oxygen. The ultrathin sections were cut and placed on nickel grids. The method of UICC used was described previously (12) . Briefly, sections were incubated with blocking solution composed of the three proteins, 5% bovine serum albumin (BSA), 5% goat normal serum, and 1% cold fish skin gelatin, and then reacted with anti-vimentin (mouse 1:100 Novocastra), anti-GFRa2 (rabbit, 1:100; Santa Cruz Biotechnology, Dallas, TX), anti-Sox2 (rabbit, 1:50; Millipore, Billerica, MA), anti-Sox9 (mouse, 1:100; Santa Cruz Biotechnology), or anti-Oct-4 (rabbit, 1/50; Santa Cruz Biotechnology) as the primary antiserum. Then, they were exposed to goat anti-mouse or anti-rabbit IgG labeled with a 15-nm gold complex (1:30; Electron Microscopy). The grids were stained with uranyl acetate (Sigma) and examined using a Zeiss LEO 906-E electron microscope. To validate the specificity of the immunostaining, we performed a negative control, replacing the primary antiserum with 1% BSA in PBS followed by the secondary antibody.
Ultrastructural morphometric analysis was performed on electron micrographs obtained from coronal sections of two different MZ areas separated from each other by 50 m in all of the experimental groups. To avoid duplicate counting of the same cell, only one large section from each block was mounted on a 200-mesh nickel grid. Then, 100 electron micrographs were taken randomly from each section at a magnification of ϫ16,700, covering 100 -200 cells/animal. Using ImageJ 1.47v (Wayne Rasband; National Institutes of Health), we counted all gold particles in the cytoplasm and the nucleus compartment per area unit, named labeling density (11) . The number of gold particles was referenced to 10 m 2 of cytoplasm or nucleus compartment.
BrdU uptake in AP and MZ cells. 5-Bromo-2=-deoxiuridina (BrdU; Sigma), which is incorporated in DNA instead of thymidine in cells in the S phase of the cell cycle, was dissolved in phosphate-buffered saline (PBS; 50 mg/ml) and injected intraperitoneally at a dose of 50 g/g rat weight 12 h before decapitation.
Four pituitary glands per experimental group were fixed in 4% buffered formaldehyde, dehydrated, and embedded in paraffin. These pituitaries were then cut, deparaffined, rehydrated, and washed in 0.1 M PBS before being treated with 3% H2O2 for 15 min to inhibit endogenous peroxidase activity, after which 5% PBS-BSA was applied for 30 min to block nonspecific binding of the secondary antibody. Pituitary sections were incubated overnight in a 1:100 solution containing anti-BrdU (GE Healthcare Life Sciences), and then the slides were washed with PBS and exposed to a biotin-labeled secondary antibody against mouse IgG at room temperature for 30 min and to ABC complex for 30 min (Vector Laboratories, Burlin-game, CA). Subsequently, the slides were immersed in a solution containing 3-3=-diaminobenzidine (Sigma) in 0.1 M Tris buffer, pH 7.2, containing 0.03% H 2O2 before being counterstained with hematoxylin, dehydrated, and cover-slipped with mounting liquid (Sigma). Negative controls were also performed by applying the same protocol, but BrdU antibody was omitted.
Three different levels from the coronal pituitary sections, including MZ and AP, which were separated from each other by 50 m, were sampled per rat and used for morphometric analysis. All results were pooled for each individual animal. Immunoreactive cells were observed using a light microscope at a magnification of ϫ400, with the number of BrdU -mmunoreactive cells being counted from two MZ layers and from a total of 5,000 AP cells obtained from random samples taken from each rat.
Immunodetection of SC/P markers and BrdU incorporation in frozen pituitary gland samples. The pituitary gland of the different experimental groups studied were placed in Crioplast (Biopack, Buenos Aires, Argentina) and immersed in liquid nitrogen for a few minutes until the solidification of the embedding medium and stored at Ϫ80°C. For immunodetections, the cryostat sections were fixed in absolute methanol, incubated with PBS-BSA 5%, and then reacted with anti-GFRa2 (rabbit, 1:100; Santa Cruz Biotechnology), antiSox2 (mouse, 1:200; Millipore), anti-Sox9 (rabbit, 1:200; Santa Cruz Biotechnology), or anti-BrdU (mouse, 1:100; GE Bioscience Healthcare). Subsequently, the slides were exposed to a secondary antibody Alexa 594 anti-rabbit (1:1,000; Invitrogen, Carlsbad, CA) or antimouse Alexa 488 (1:1,000; Invitrogen, Eugene, OR) for 1 h at room temperature and mounted with fluoromount (Sigma) containing DAPI.
For double immunodetection, analysis was performed on consecutive days to avoid nonspecific immunolabeling given by the secondary antibody. Briefly, during the 1st day, samples were incubated with BrdU (mouse, 1:100), GFRa2 (rabbit, 1:100), Sox9 (rabbit, 1:200), or prolactin (PRL; rabbit 1:10,000; National Hormone and Pituitary Program, Torrance, CA) antibodies. Then they were washed with PBS and exposed to a secondary antibody labeled with Alexa 594 (1/ 1,000). On the 2nd day, the samples were washed with PBS and incubated with BrdU. Then they were reacted with secondary antibody Alexa 488 (1:1,000). To validate the specificity of the immunostaining, negative controls were performed by applying the same protocol but replacing primary antibody with 5% PBS-BSA.
Laser capture microdissection and RNA isolation. The pituitary glands of rats corresponding to the G and L groups were immersed in buffer solution with 0.1 M Tris, zinc salts (5 g of ZnCl 2, 6 g of ZnAc2.2 H2O, and 0.1 g of CaAc2), and 30% sucrose and then frozen in tissue-freezing medium (Crioplast; Biopack, Buenos Aires, Argentina). These samples were cut into 15-m sections using a cryostat (Shandon Cryotome SME), transferred to polyethylene naphthalate membrane, fixed in 70% ethanol at Ϫ20°C, and dehydrated on activated silica. MZ and AP regions were morphologically identified and captured using laser dissection microscopy (Leica LDM6000). Dissected areas were collected, and the total RNA was isolated using an illustra RNAspin Mini RNA Isolation Kit (GE Healthcare Life Sciences), following the manufacturer's recommendations.
Complementary DNA synthesis was performed by incubating 11 l of total RNA extracted from MZ and AP regions with 9 l of reverse-transcription reaction mixture containing 4 l of FS buffer (5ϫ), 1 l of dNTPs (10 mM), 1 l of random hexamers (50 -250 ng), 1 l of M-MLV reverse transcriptase (200 U/l), 0.5 l of RNase out (40 U/l), and 1.5 l of DTT (0.1 M). Reverse-transcription reaction was performed on a 5332 Eppendorf Mastercycler using the following temperature cycle: 10 min at 70°C, 1 min on ice, 10 min at 25°C, 1 h at 37°C, and 15 min at 70°C.
Gene expression analysis by quantitative PCR. Real-time PCR analysis was performed on an ABI Prism 7500 detection system (Applied Biosystems, Foster City, CA) using Power SYBR Green PCR Master Mix (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA). The gene-specific primer sets are described in Table  1 . Relative changes in gene expression were calculated using the 2 Ϫ⌬⌬CT method normalized against the housekeeping gene ␤-actin. For each pair of primers, a dissociation plot resulted in a single peak, indicating that only one cDNA species was amplified. Amplification efficiency for each pair of primers was calculated using standard curves generated by serial dilutions of cDNA obtained from embryos at 10 wk of gestation. All primers were from GBT Oligos Genbiotech (Buenos Aires, Argentina).
Statistical analysis. Statistical analysis was carried out using an analysis of variance with the Tukey posttest (SPSS Statistics for Windows, version 17.0). The results are given as means Ϯ SE, and the data were obtained from three replicates measured for three independent experiments. The significance level chosen was P Ͻ 0.05.
RESULTS
Characterization and topographic localization of the SC niche in the MZ. First, we attempted to localize topographically the MZ and study the morphology of the cells sited in this area by high-resolution light and electron microscopy. The MZ is composed of two layers of cells (Fig. 1) , with one of these outlining the cleft and the other situated below in tight contact. The cells that composed the first layer of the MZ had in general a cuboid appearance with an increased nucleus/cytoplasm relationship and an absence of secretory granules in the cytoplasm. Some of these cells possessed apical extensions such as cilia and microvilli, which are hallmarks associated with the SC phenotype, and the cells that presented microvilli and cilia Oct-4 Forward: 5=-ACACCTGGCTTCAGCTTCG-3= NM_001009178 (89-448) Reverse: 5=-CAGAGTCTCCACGCCAACTT-3= Sox2
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in the apical membrane were oriented toward the cleft (Fig. 2) . The second MZ layer is composed of cells with similar morphological characteristics described for SC and others with a fusiform shape similar to supporting cells referred to as mesenchymal cells (MC).
To characterize completely the SC niche, we identified a marker of supporting MC such as vimentin by UICC. Vimentin expression was observed in MZ cells, being dispersed in the cytoplasm and unassociated with the organelles. These vimentin-positive cells were arranged below the first line MZ cells (Fig. 3, A and B) .
Subcellular localization of markers associated with the SC/P phenotype. Subcellular localization and the distribution of markers associated with the SC/P phenotype at the MZ of adult pituitaries were analyzed by UICC. The expression of Oct-4 and GFRa2 was intense in cells localized at the region around the cleft, which then decreased toward the adenohypophysis. In particular, the GFRa2 expression was dispersed in the cytoplasm of cells localized in the first layer of the MZ (Fig. 4A) , with Oct-4 being observed in the nucleus and cytoplasm of these cells (Fig. 4B) . In addition, both SC markers were observed in cells with apical membrane differentiations. The expression of Sox2 and Sox9 was observed in the first line of MZ cells and also in cells with morphological SC characteristics that composed the second MZ line. An interesting observation was that Sox2 had a remarkable immumoreactivity within the nucleus of MZ cells. Meanwhile, Sox9 immunogold labeling was weaker in the nucleus and cytoplasm of cells localized in this zone (Fig. 4, C and D) .
In parallel, we performed assays using immunofluorescence microscopy to search for and identify GFRa2-, Sox2-, or Sox9-positive cells in the adult pituitary gland. As shown in Fig. 4 , E and F, we observed GFRa2-and Sox2-positive cells, respectively, in the AP as a few sparse cells, whereas Sox9-positive cells were observed to be scattered in AP and are displayed in Fig. 4G .
Analysis of mRNA levels of SC/P and committed cell markers in the MZ and adenoparenchyma during gestation and lactancy. To assess whether the stemness, progenitor markers, and gene expression associated with committed cells exhibited any changes in the MZ and AP during the reproductive states under study, we used laser capture microdissection to individually isolate each zone. Total RNA was isolated and the mRNA expression of marker genes evaluated by real-time PCR.
Gene expression in the MZ. The mRNA levels of the SC markers GFRa2, Sox2, and Oct-4 exhibited the highest expression at the end of gestation (AT) compared with their expression at earlier gestation stages. Moreover, we observed a significant decrease in the expression of these markers during lactancy (Fig. 5A1) . The progenitor gen marker Sox9 displayed a different expression pattern during the reproductive stages, showing a twofold increase at d15G before returning to basal levels at term of gestation but exhibiting a significant increase at 4 days of active lactancy (Fig. 5A2) . The expression of the lineage-committed markers Prop1 and Pit-1 did not exhibit any significant variations during gestation. Nevertheless, we observed a significant increase in the expression levels of Prop1 and Pit-1 at AT and early lactancy compared with their expression during gestation (Fig. 5A3) .
Gene expression in the adenoparenchyma. The GFRa2, Oct-4, and Sox2 mRNA levels showed a significant reduction at d5G and d15G with respect to COP, although Oct-4 mRNA exhibited an increase at AT. The lactancy stimuli induced a striking rise in GFRa2 mRNA levels but a significant reduction in the Sox2 and Oct-4 mRNA levels (Fig. 5B1) . Conversely, Sox9 mRNA levels did not show significant variations during gestation and lactancy stages (Fig. 5B2) .
For the period of gestation, the mRNA levels of the lineagecommitted marker Prop1 did not show a significant modification. Meanwhile, Pit-1 mRNA expression showed a significant increase at d15G and AT. In addition, at early lactancy, Prop1 and Pit-1 mRNA displayed a significant increase. However, after 4 days of lactancy, Prop1 mRNA levels decrease and Pit-1 return to AT levels (Fig. 5B3) . In addition, we analyzed the relationship between Pit-1/Prop1 in MZ vs. AP. In MZ, Prop1 expression was greater than Pit-1 in AT (0.69 Ϯ 0.085) and d1L (0.70 Ϯ 0.058), whereas this relation was inverted (P Ͻ 0.05) in AP of the same groups (AT: 1.81 Ϯ 0.14; d1L: 1.70 Ϯ 0.23).
Expression of SC/P markers in MZ cells during gestation and lactancy.
To evaluate the expression of the SC/P markers GFRa2, Oct-4, Sox2, and Sox9 in MZ cells throughout different reproductive states such as gestation and lactancy, we quantified the immunogold labeling using an electron microscope. This technique is a reliable tool and allowed us to quantify the markers of SC/P cells localized specifically in MZ and to determine their possible fluctuations in response to changes in hormonal surges during physiological conditions.
GFRa2. GFRa2 expression in the cytoplasm of MZ cells quantified by morphometric analysis was similar at COP and d5G. However, there was a marked reduction in the middle of the gestation (d15G) compared with COP (P Ͻ 0.05) but a noticeable increase at term of gestation. At the beginning of lactancy, the GFRa2 expression revealed a significant decrease (P Ͻ 0.05 vs. AT), with this level maintained after 4 days of lactancy (Fig. 6A) .
Oct-4 and Sox2. The Oct-4 expression quantified in the cytoplasmic compartment of the MZ cells was similar at COP and gestation (d5G, d15G). In contrast, the immunolabeled nuclear Oct-4 exhibited a significant decrease in the middle of gestation and at AT. During active lactancy (d4L), the nuclear and cytoplasmic Oct-4 expression showed a great increase compared with at AT (P Ͻ 0.01), but no significant differences between nuclear and cytoplasmic compartments were observed at COP, gestation, or early lactancy. However, in d4L, the immunolabeled Oct-4 revealed a different subcellular distribution, as a higher expression in the cytoplasm than in the nuclear compartment was observed (Fig. 6B) .
The Sox2 expression exhibited a different subcellular distribution pattern, displaying higher levels in the nuclear compared with the cytoplasmic compartment at COP and d15G (COP CC vs. NC, P Ͻ 0.05, and d15G CC vs. NC, P Ͻ 0.01). During active lactancy, the expression of this marker in both subcellular compartments showed remarkable increases (d4L vs. AT, P Ͻ 0.01; Fig. 6C ).
Sox9. The Sox9 expression was analyzed in both the nuclear and cytoplasmic compartments of cells localized in MZ during the gestation and lactancy groups. The morphometric study showed a significant decrease in Sox9 immunolabeled within the cytoplasmic compartment during gestation at d5G and d15G compared with at COP, with a noticeable dimi- nution also being observed in the d5G nuclear expression (P Ͻ 0.05 vs. COP) of this marker. However, this subcellular compartment displayed a significant increase at AT with respect to COP.
At early lactancy (d1L), the Sox9 expression determined in both subcellular compartments of MZ cells exhibited a remarkable increase compared with AT (P Ͻ 0.01 vs. AT) but decreased significantly after 4 days of active lactancy (Fig. 6D) . Fig. 4 . Immunodetection of stem/progenitor cell (SC/P) markers in the MZ and adenoparenchyma (AP) of adult rat pituitary glands by electron and fluorescence microscopy. A: immunoelectron micrographs of Glial cell line-derived neurotropic factor (GDNF) receptor-␣2 (GFRa2)ϩ cell localized in the 1st MZ layer displaying cilia at the apical membrane. Dotted square shows the location of the inset zone. The GFRa2ϩ cell exhibits moderate immunoreactivity in the cytoplasm near the plasma membrane. Original magnification, ϫ10,000. B: Oct-4ϩ cell identified by ultrastructural immunocytochemistry exhibiting microvilli in the apical membrane is situated in the 1st MZ layer. Immunogold labeling is intense at the cytoplasm. C: nucleus of the Sox2ϩ cell exhibits a stronger immunoreactivity than that observed in the cytoplasmic matrix using the colloidal gold technique. 7F ). Interestingly, more BrdU-immunopositive cells were observed in the first layer of MZ than in the second one (Fig.  7, A-E) .
Adenoparenchyma cell proliferation. The number of BrdUimmunopositive AP cells was significantly higher at d5G than at COP (3.20 Ϯ 0.05 and 2.29 Ϯ 0.02%, respectively), with a significant decrease at term of gestation resulting in values similar to those at COP. In the early lactancy group, the proliferation of adenohypophysial cells showed a rise of 1.5-fold with respect to the values quantified at AT (3.59 Ϯ 0.3 and 2.29 Ϯ 0.09%, respectively), followed by a decrease of about eightfold at d4L (0.46 Ϯ 0.07%) (Fig. 8, A-F) .
Coimmunodetection of BrdU with GFRa2 or Sox9 expression. Finally, we carried out a double-immunofluorescence assay for BrdU uptake and GFRa2, a pituitary-specific SC marker that exhibited a high expression in the AT group, in which the BrdU incorporation peak was observed in the MZ. As shown in Fig. 9, A and B, the coimmunodetection for BrdU and GFRa2 in MZ cells was more evident in the AT group, attaining a twofold increase compared with the COP group (2.36 Ϯ 0.72 and 0.29 Ϯ 0.29%, respectively; Fig. 9C ).
Bearing in mind that in the AP the highest cell proliferation values were observed in early lactancy and that Sox9 participated in the expansion of the progenitor cell population, we compared the percentage of BrdU-and Sox9-positive cells in AP vs. MZ (Fig. 9, D and E) and found that the number of BrdU-positive cells that expressed the Sox9 marker was significantly greater in the AP than the MZ in the d1L group (3.06 Ϯ 0.43 vs. 1.22 Ϯ 0.23%, respectively). In addition, we carried out a double-immunofluorescence assay for Sox9 and PRL, the main hormone expressed during lactancy. As shown in the Fig. 9F , only a few cells coexpressed Sox9 and PRL in the AP of the d1L. AT; Oct-4: P Ͻ 0.05 d1L and d4L vs. AT; Sox2:
ٙ P Ͻ 0.05 d1L and d4L vs. AT]. A2: Sox9 increased at d15G and d4L (*P Ͻ 0.05 d15G vs. COP; OEP Ͻ 0.05 d4L vs. AT). A3: Prop1 and Pit-1 show the highest levels at AT and early lactancy (*P Ͻ 0.05 AT vs. COP; OEP Ͻ 0.05 d1L vs. COP). B1-B3: GFRa2, Oct-4, Sox2, Sox9, Prop1 and Pit-1 mRNA levels quantified in AP. B1: SC markers decrease during gestation (GFRa2: *P Ͻ 0.05, d5G, d15G, and AT vs. COP; Oct-4: oP Ͻ 0.05, d5G and d15G vs. COP; Sox2: {P Ͻ 0.05 d5G and d15G vs. COP). However, in AT rats, Oct-4 mRNA exhibits an increase with respect to at COP (OEP Ͻ 0.05, AT vs. COP). The GFRa2 shows the highest levels at d1L (OEP Ͻ 0.05, d1L vs. AT), whereas Sox2 does not evidence any significant changes in all groups analyzed. B2: Sox9 progenitor marker does not exhibit any variations during gestation or lactancy. B3: Pit-1 levels show increase from the middle of gestation to early lactancy (P Ͻ 0.05 d15G and AT vs. COP; ٙ P Ͻ 0.05 d1L vs. AT), whereas Prop1 exhibits an increase at d1L (OEP Ͻ 0.05 d1L vs. AT). The mRNA expression was relatively quantified to that of ␤-actin. Results are shown as fold change of the mRNA levels for COP and AT groups. Data are representative of 3 independent experiments and were analyzed by ANOVA-Tukey test.
DISCUSSION
In the present study, we have demonstrated the participation of pituitary SC in the physiological cell turnover from fluctuations in SC/P mRNA and the protein level markers in combination with significant changes in the MZ cell proliferation rate, which took place during gestation and lactancy. Taking these findings into consideration, it appears that the SC pituitary niche actively participates in pituitary plasticity during these reproductive states, thereby being involved in the origin of mature hormone cell populations.
A stem cell niche is defined not only by the presence of tissue SC but also by the characterization of somatic support cells, which secrete essential factors for the maintenance of pluripotency in resident stem cells (51) . An SC niche has been reported in the pituitary gland based on the detection of SC/P and mesenchymal cell markers in MZ by immunofluorescence (15, 19, 42 ). In the current investigation, we confirmed the presence of an adult pituitary SC niche and described for the first time through ultrastructural analyses the organization of MZ cells into two layers. GFRa2 and Oct-4 were expressed in the first layer of MZ cells, with some of these cells exhibiting microvillus and cilia in the apical membrane, thereby suggesting that they maintained the primary cilium as observed previously in the mitosis of embryonic cells that retained stem cell features (6) . In both MZ layers, we identified Sox2-and Sox9-immunolabeled cells, whereas the vimentin-supporting cell marker (33) was visualized only in some cells of the second layer of this zone, which were precisely localized, surrounding the first layer of MZ cells. Moreover, in the AP of the adult pituitary gland, the GFRa2, Sox2, and Sox9 single positive cells and a few sparsely distributed groups were observed. In line with these results, it has been reported recently that scattered cells throughout the AP are positive for GFRa2 in the adult gland (18) in addition to some other previously identified SC markers such as Sox2, Sox9, and Klf4 (7, 20) . These findings suggest the existence of multiple SC Fig. 6 . Analysis of SC/P marker expression patterns in the cytoplasmic (CC) and nuclear (NC) compartments of the MZ cells. A: GFRa2 expression displays a remarkable increase at term of gestation. *P Ͻ 0.05, AT vs. COP; ٙ P Ͻ 0.05, d15G vs. COP; P Ͻ 0.05, d1L and d4L vs. AT. B: Oct-4 marker shows an increase in nuclear and cytoplasmic compartments in active lactancy. P Ͻ 0.01, d4L vs. AT; *P Ͻ 0.01, d15G and AT vs. COP (NC). C: a differential Sox2 distribution is exhibited between the nuclear and cytoplasmic compartments at COP ( ٙ P Ͻ 0.05, NC vs. CC) and d15G ({P Ͻ 0.01 NC vs. CC), whereas in active lactancy Sox2 is increased in both subcellular compartments P Ͻ 0.01, d4L vs. AT. D: Sox9 marker expression displays an increase at early lactancy in both the nucleus and cytoplasm. P Ͻ 0.01, d1L vs. AT, with a notable decrease observed at d4L; e P Ͻ 0.05, d4L vs. AT; *P Ͻ 0.05, d5G and d15G vs. COP (CC); P Ͻ 0.05 d5G vs. COP and }P Ͻ 0.05 AT vs. COP (NC). Results are given as means Ϯ SE from 3 independent experiments. The data were analyzed by the ANOVA-tukey test.
niches that could be favorable for dynamic and/or subtle cell adaptations.
A mitotic variability was described in the anterior pituitary of female rats (38, 56) in the estrous cycle and also during pregnancy and lactation (5, 13, 14) , with estrogen being the principal cause for the increased lactotroph cell population (31) . Considering the evidence of an SC/P niche in the adult pituitary and in an attempt to achieve a better understanding of the new endocrine cell supply during the cell turnover that occurs in states such as reproduction, we evaluated in vivo the SC/P contribution to the cell differentiation during gestation and lactancy. There is consistent evidence that GFRa2ϩ cells are located in the MZ of the adult pituitary (19) , in agreement with our findings. However, little is known about their participation during new endocrine cell production. Our study revealed a noticeable increase in GFRa2 expression in the MZ at the end of gestation, suggesting its involvement in the SC recruitment that occurs in the MZ, thus giving rise to a progenitor cell population. Related to this, a recent report described that the upregulation of Ret receptor and its coreceptors GFRa1, GFRa2, and GFRa3 is key for hematopoietic SC survival and pluripotency and allows these cells to be distinguished from progenitor ones in the fetal liver (16) . On the other hand, the greater mRNA GFRa2 expression in AP vs. MZ may have been related partly to the hormonal fluctuations that have been widely described in COP and lactation states, suggesting that the GFRa2ϩ AP cell groups may not represent isolated focal spots. Therefore, as described previously, the SC/P AP cell groups may be establishing a three-dimensional cooperating network throughout the gland, thereby allowing long-range communication between the stem cells, which would be important in coordinating their maintenance, proliferation, and differentiation activities (29, 34) .
The other principal factors implicated in the maintenance of pluripotency in adult SC such as Oct-4 and Sox2 exhibited a notable increase in the mRNA levels in the MZ from the AT pituitary group. In addition, their protein expression levels showed an important rise in the active lactancy group (d4L). This dissociation observed between transcription and translation has also been reported for these markers in other studies performed at the early stages of the embryonic stem cell differentiation process, indicating that translational and posttranslational regulatory mechanisms have important roles in SC fate decisions and may reflect the nature of a The d5G and d15G groups exhibit a decrease in BrdU (*P Ͻ 0.01, d5G and d15G vs. COP) but then a notable rise at AT (P Ͻ 0.01, AT vs. COP), which is followed by a decrease during lactancy ({P Ͻ 0.01, d1L and d4L vs. AT). The BrdU-positive nuclei staining is expressed as the percentage of the total nuclei counted from 2 MZ cell layers obtained for each rat. The data are shown as means Ϯ SE of 4 animals/group, with data being analyzed using the ANOVA-Tukey test. complex regulatory network in the stem fate choice process (4, 43) .
A singular subcellular distribution of Sox2 expression was observed at COP and in the middle of the gestation, which was localized more frequently in the nuclear than in the cytoplasmic compartment of MZ cells. The nuclear Sox2 expression has been related to its role as gatekeeper of the pluripotency in embryonic and adult SC (25, 46) , whereas the exclusion of Sox2 from the nucleus by nucleocytoplasmic shuttling, for instance, is associated with the inhibition of its activity, thereby allowing pituitary endocrine differentiation (17) . In the current study, the mRNA of the progenitor marker Sox9 showed an increase at d15G and active lactancy, whereas its protein levels rose at d1L. These fluctuations detected allowed us to hypothesize that Sox9 could have participated during the activation of the SC/P niche during gestation and lactancy through the expansion of a progenitor cell population, thus acquiring a transitional state before choosing a definitive fate.
The expression of the organ-specific factors Prop1 and Pit-1 may reveal a cell population at a committed precursor stage in the course of differentiation to a specific cell type (54) . The mRNA levels of these markers displayed an interesting increase in the MZ and AP in AT and in the early and active lactancy groups. In particular, Prop1 exhibited a noticeable mRNA increment at d1L in the MZ, whereas Pit-1 showed a similar behavior at in AP. We also analyzed the relationship between PROP1/Pit-1 in MZ vs. AP. In MZ, the PROP1 expression was greater than Pit-1 in AT and d1L, whereas this relation was inverted in AP for the same groups. It is possible that the low PROP1 mRNA levels compared with the high Pit-1 levels in AP could have been related to the initiation of differentiation programs similar to those occurring during embryonic development of the hormonal cells (7, 57, 59) .
Accumulating evidence has indicated a marked plastic adaptation (21) of the adult pituitary gland occurring mainly in response to hormonal stimulus in the reproductive states (45) . Classically, during gestation and lactancy, an increase in the adenohypophysial cell proliferation has been described in humans and rats (1, 24) . However, in recent years, it has been shown that the trophic activity under basal conditions as well as in response to hormonal stimuli also occurs in cells that are not hormonally active (36) . To date, however, there are no studies that have investigated a differential cell proliferation in the MZ or AP cells during remodeling of the hormonal cells. Therefore, we performed an analysis of the incorporation of BrdU in MZ and AP cells. A remarkable fluctuation in BrdU The BrdU incorporation in AP increases at d5G (*P Ͻ 0.05, d5G vs. COP) and at early lactancy (P Ͻ 0.05, d1L vs. AT), after which a reduction at d4L is observed (OEP Ͻ 0.05, d4L vs. AT). The BrdU-positive nuclei staining is expressed as the percentage of the total nuclei counted from a total of 5,000 AP cells obtained from randomized samples for each rat. The data are shown as means Ϯ SE of 4 animals/group, with data being evaluated using the ANOVA-Tukey test.
uptake was observed in MZ cells, showing a significant rise at AT. A different pattern of BrdU uptake was described in AP, with an increase being detected at early lactancy followed by decrease at d4L in the number of BrdU-positive cells in both the MZ and AP zones. Considering the upregulation of SC markers and the increase in cell proliferation in the MZ of the AT group, an expansion of the SC niche in the MZ at term of gestation may be proposed. On analyzing the proliferating cells that expressed the GFRa2 marker in the MZ at term of gestation, a significant increase in BrdU-GFRa2ϩ cells was observed in the MZ of the AT group, indicating that the pituitary SC that were in a rest condition may have reentered the cell cycle to supply the physiological demands, as reported previously in other adult tissues (52) . In a recent report using the lineage-tracing experiment, it was demonstrated that pituitary stem cells are derived from the embryonic Rathke's pouch progenitors and that they continue to proliferate and differentiate to contribute to postnatal pituitary growth (60) . For the progenitor marker, we compared the Sox9-proliferating cells in the MZ vs. AP of the d1L group, which described the highest cell proliferation values and observed that the positive cells were significantly greater in the AP. These findings suggest an expansion of the SC pituitary MZ niche at the end of gestation, which may then be mobilized to the AP region as Sox9ϩ progenitor cells, thus making it possible to differentiate in specific types of endocrine cells at early lactancy.
In conclusion, in the present study, we detected oscillatory patterns in the mRNA and protein levels of the SC/P markers in combination with a remarkable fluctuation in the cell proliferation rate in the MZ during the gestation and lactancy. These data are indicative of a pituitary SC/P niche contribution to supply the demand for new endocrine cells in the reproduc- tive states studied. A future better understanding of this mechanism may provide significant insights into pituitary SC/P fate choice and also help to shed light on the pituitary plasticity displayed in the physiological environment.
